Evidence map›Paper›PMID 33933103›Full record

ArticleSubstance abuse treatment, prevention, and policy2021

Qualitative assessment of patients' perspectives and needs from community pharmacists in substance use disorder management.

Sarah Fatani, Daniel Bakke, Marcel D'Eon, Anas El-Aneed

Abstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies.International journal of mental health and addiction · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah FataniCollege of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Room 3D01.3, Saskatoon, Saskatchewan, S7N 5E5, Canada.
Daniel BakkeCollege of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Room 3D01.3, Saskatoon, Saskatchewan, S7N 5E5, Canada.
Marcel D'EonEducation Innovation Institute, Medical College of Georgia, Augusta University, Augusta, USA.
Anas El-AneedCollege of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Room 3D01.3, Saskatoon, Saskatchewan, S7N 5E5, Canada. Anas.el-aneed@usask.ca.ORCID 0000-0003-1060-3609

Funding

CIHR
6 · The paper itself

Abstract

backgroundNon-medical use of psychoactive substances is a common harmful behavior that leads to the development of Substance Use Disorders (SUDs). SUD is a significant health concern that causes adverse health consequences and elevates the economic burden on the health care system. SUD treatment plans that utilize a patient-centered approach have demonstrated improved treatment outcomes. It is essential for health care providers, including community pharmacists, to understand patients' needs and prioritize them. Therefore, this study was conducted to explore the perspective of patients living with SUDs or who used substances non-medically regarding community pharmacist services and the delivery of services in a community pharmacy setting. The study took place in Saskatoon, a small urban center of Saskatchewan, Canada.

methodsQualitative methodology was used for this research inquiry. Four focus groups were conducted, with a total of 20 individuals who had experienced substance use and accessed community pharmacy services. The discussion of the four focus groups was transcribed verbatim and analyzed independently by two researchers. Agreement on the emergent themes was reached through discussion between the two researchers.

resultsData analysis resulted in four themes that described participants' perspectives about community pharmacists. The four emergent themes are: 1) conflicted experiences with community pharmacists, 2) lack of knowledge concerning community pharmacists' extended services, 3) negative experiences in Opioid Agonist Therapy (OAT) program, and 4) needs from community pharmacists.

conclusionThere is significant potential for the patient-pharmacist relationship to address the varying needs of patients who use substances and improve their overall health care experience. Patients who use substances are receptive to pharmacists' services beyond dispensary; however, respectful communication, provision of drug-related information, and counseling are among the primary demands. Future research should focus on studying the impact of meeting the needs of patients on their treatment outcomes.

Indexed as

Community Pharmacy ServicesSubstance-Related DisordersAttitude of Health PersonnelHumansPharmacistsProfessional RoleQualitative ResearchCommunity pharmacistsMethadoneQualitative studySubstance use disorder

Identifiers

PMID33933103
PMCPMC8088612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.